Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.

NCT05628116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: XC243 50 mg single
DRUG: XC243 100 mg single
DRUG: Placebo single
DRUG: XC243 200 mg single-dose food effect
DRUG: Placebo single-dose food effect
DRUG: XC243 200 mg multiple
DRUG: Placebo multiple

Sponsor

PHARMENTERPRISES LLC